United Therapeutics Corporation (NASDAQ: UTHR) has acquired Thymmune Therapeutics, Inc., a privately held, preclinical-stage biotechnology company focused on thymic cell ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions